Journal of cutaneous pathology · 2020
Germline mutations predisposing to melanoma.
Сравнительное исследованиеСтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Toussi Atrin, Mans Nicole, Welborn Jeanna, Kiuru Maija
Аннотация
Nearly 15% of melanomas occur in patients with a family history and a subset of these patients have a germline mutation in a melanoma predisposing gene. CDKN2A mutations are responsible for the majority of hereditary melanoma, but many other susceptibility genes have been discovered in recent years, including CDK4, TERT, ACD, TERF2IP, POT1, MITF, MC1R, and BAP1. Additionally, melanoma risk is increased in mixed cancer syndromes caused by mutations in PTEN, BRCA2, BRCA1, RB1, and TP53. While early onset, multiple tumors, and family cancer history remain the most valuable clinical clues for hereditary melanoma, characteristic epithelioid cytology of melanocytic tumors may suggest an underlying BAP1 mutation. Herein, we review the clinical and histopathologic characteristics of melanocytic tumors associated with these germline mutations and discuss the role of genetic counseling.
Предметные рубрики MeSH
AdolescentAdultAgedAged, 80 and overCyclin-Dependent Kinase 4Cyclin-Dependent Kinase Inhibitor p16Genes, p16Genetic Predisposition to DiseaseGerm-Line MutationHumansMelanomaMicrophthalmia-Associated Transcription FactorMiddle AgedNevus, PigmentedPhenotypeReceptor, Melanocortin, Type 1Shelterin ComplexTelomeraseTelomere-Binding ProteinsTumor Suppressor ProteinsUbiquitin ThiolesteraseYoung Adult